C/EBPα Activates Pre-existing and De Novo Macrophage Enhancers during Induced Pre-B Cell Transdifferentiation and Myelopoiesis
about
Influence of Rotational Nucleosome Positioning on Transcription Start Site Selection in Animal PromotersLogical modeling of lymphoid and myeloid cell specification and transdifferentiation.The novel tool of cell reprogramming for applications in molecular medicine.C/EBPα creates elite cells for iPSC reprogramming by upregulating Klf4 and increasing the levels of Lsd1 and Brd4.In vivo conditional deletion of HDAC7 reveals its requirement to establish proper B lymphocyte identity and development.Pioneer transcription factors, chromatin dynamics, and cell fate control.Cell fate modification toward the hepatic lineage by extrinsic factors.Runx1 Structure and Function in Blood Cell Development.Direct lineage reprogramming via pioneer factors; a detour through developmental gene regulatory networks.MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.A Transcription Factor Pulse Can Prime Chromatin for Heritable Transcriptional Memory.C/EBP-Induced Transdifferentiation Reveals Granulocyte-Macrophage Precursor-like Plasticity of B Cells.Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular Reprogramming.Alemtuzumab-based therapy for Secondary Malignant Histiocytosis arising from Pre-B-ALL.Transcription factors orchestrate dynamic interplay between genome topology and gene regulation during cell reprogramming.Pioneer factor Pax7 deploys a stable enhancer repertoire for specification of cell fate.Pioneer transcription factors shape the epigenetic landscape.Osmotic modulation of chromatin impacts on efficiency and kinetics of cell fate modulation.Direct Cardiac Reprogramming: A Novel Approach for Heart Regeneration
P2860
Q27315870-7F2E1DDA-93DA-4DAB-AC50-1D809521B374Q30855561-93051CB7-6F4C-43D6-8A98-D6B9C5820DE6Q33843720-7648D50B-A75D-44CE-8D20-4715E3B927B9Q34046454-16E50040-F1B4-47CD-AAD2-7DC8E991006FQ37415191-7CB0D73C-AE1A-47FE-9F61-F46401F534E9Q38716695-0219A19D-25EB-42EF-AD2B-6EB56AC359C0Q38730766-778A1019-67E9-4AB9-87CD-FA14C41BD6FAQ38904253-57134B83-2964-4E72-9743-B975F5AC8165Q38916937-51BF1E7B-7219-46BD-A875-7F03E7A8ACC9Q39031605-39F68462-416A-4841-8256-E3B7E52EF194Q42140535-891F4357-ACE2-45E4-900E-C9D173D21918Q42321116-3083061D-D6B9-49E3-BD17-53A75E510A8CQ47139123-1C3E6730-E45C-4D6C-819D-5869AE36A3D4Q47143695-DB9D76E7-6BB9-4E94-8872-DA407B71FC20Q48042855-30F48A35-898F-4B3A-9C12-386BB34BEBCDQ48190662-ED8D2BD3-0C4C-475A-8053-3B81E1FAE08EQ50532548-7673C977-2507-4824-9329-14FF0DDC18A6Q55402972-EE7B373D-636D-4F32-AAC1-2DE5D5741B35Q58762437-5374AB16-90B2-4422-9848-7F4588C8B8F4
P2860
C/EBPα Activates Pre-existing and De Novo Macrophage Enhancers during Induced Pre-B Cell Transdifferentiation and Myelopoiesis
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
C/EBPα Activates Pre-existing ...... fferentiation and Myelopoiesis
@ast
C/EBPα Activates Pre-existing ...... fferentiation and Myelopoiesis
@en
type
label
C/EBPα Activates Pre-existing ...... fferentiation and Myelopoiesis
@ast
C/EBPα Activates Pre-existing ...... fferentiation and Myelopoiesis
@en
prefLabel
C/EBPα Activates Pre-existing ...... fferentiation and Myelopoiesis
@ast
C/EBPα Activates Pre-existing ...... fferentiation and Myelopoiesis
@en
P2093
P2860
P50
P1433
P1476
C/EBPα Activates Pre-existing ...... fferentiation and Myelopoiesis
@en
P2093
Aimee Badeaux
Chris van Oevelen
Cyrille Lepoivre
Lars Bussmann
Miguel Beato
Samuel Collombet
P2860
P304
P356
10.1016/J.STEMCR.2015.06.007
P577
2015-07-30T00:00:00Z